Literature DB >> 14744243

Identification of the major steps in botulinum toxin action.

Lance L Simpson1.   

Abstract

Botulinum toxin is a uniquely potent substance synthesized by the organisms Clostridium botulinum, Clostridium baratii, and Clostridium butyricum. This toxin, which acts preferentially on peripheral cholinergic nerve endings to block acetylcholine release, is both an agent that causes disease (i.e., botulism) as well as an agent that can be used to treat disease (e.g., dystonia). The ability of botulinum toxin to produce its effects is largely dependent on its ability to penetrate cellular and intracellular membranes. Thus, toxin that is ingested or inhaled can bind to epithelial cells and be transported to the general circulation. Toxin that reaches peripheral nerve endings binds to the cell surface then penetrates the plasma membrane by receptor-mediated endocytosis and the endosome membrane by pH-induced translocation. Internalized toxin acts in the cytosol as a metalloendoprotease to cleave polypeptides that are essential for exocytosis. This review seeks to identify and characterize all major steps in toxin action, from initial absorption to eventual paralysis of cholinergic transmission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744243     DOI: 10.1146/annurev.pharmtox.44.101802.121554

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  174 in total

Review 1.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  The case of botulinum toxin in milk: experimental data.

Authors:  Oliver G Weingart; Tanja Schreiber; Conny Mascher; Diana Pauly; Martin B Dorner; Thomas F H Berger; Charlotte Egger; Frank Gessler; Martin J Loessner; Marc-Andre Avondet; Brigitte G Dorner
Journal:  Appl Environ Microbiol       Date:  2010-04-02       Impact factor: 4.792

Review 3.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

Review 4.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

5.  A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites.

Authors:  Christiane G Frick; Heidrun Fink; Manfred Blobner; Jeevendra Martyn
Journal:  Anesth Analg       Date:  2011-10-14       Impact factor: 5.108

6.  The role of exoproteases in governing intraneuronal metabolism of botulinum toxin.

Authors:  Lance L Simpson; Andrew B Maksymowych; Hirokazu Kouguchi; Garrett Dubois; Roop S Bora; Suresh Joshi
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

7.  Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains.

Authors:  Giovanna Franciosa; Francesca Floridi; Antonella Maugliani; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

8.  The identification and biochemical characterization of drug-like compounds that inhibit botulinum neurotoxin serotype A endopeptidase activity.

Authors:  Shuowei Cai; Paul Lindo; Jong-Beak Park; Kruti Vasa; Bal Ram Singh
Journal:  Toxicon       Date:  2009-12-07       Impact factor: 3.033

9.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

Authors:  Min Dong; Huisheng Liu; William H Tepp; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

Review 10.  Considering protonation as a posttranslational modification regulating protein structure and function.

Authors:  André Schönichen; Bradley A Webb; Matthew P Jacobson; Diane L Barber
Journal:  Annu Rev Biophys       Date:  2013-02-28       Impact factor: 12.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.